Health Care & Life Sciences » Pharmaceuticals | AFC-HD AMS Life Science Co. Ltd.

AFC-HD AMS Life Science Co. Ltd. | Cash Flow

Fiscal year is September-August. All values JPY Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
977
494
956
755
637
Depreciation, Depletion & Amortization
598
509
439
396
384
Other Funds
-
109
136
177
10
Funds from Operations
1,425
487
1,022
840
1,147
Changes in Working Capital
151
406
165
15
622
Net Operating Cash Flow
1,576
893
857
854
526
Capital Expenditures
540
229
258
163
852
Sale of Fixed Assets & Businesses
-
-
-
14
1
Purchase/Sale of Investments
187
33
162
58
16
Net Investing Cash Flow
351
260
86
220
847
Cash Dividends Paid - Total
119
177
119
180
181
Issuance/Reduction of Debt, Net
678
782
652
630
126
Net Financing Cash Flow
827
1,068
907
987
46
Net Change in Cash
398
435
136
352
367
Free Cash Flow
1,036
664
599
691
326
Other Sources
3
102
-
1
20
Change in Capital Stock
30
-
-
-
-
Other Uses
-
100
5
-
-

About AFC-HD AMS Life Science Co.

View Profile
Address
3-6-36 Toyoda
Shizuoka Shizuoka 422
Japan
Employees -
Website http://www.ams-life.com
Updated 09/14/2018
AFC-HD AMS Life Science Co., Ltd. engages in the manufacture of health food and cosmetics. It operates through the Health Care Business and Pharmaceuticals Business segments. The Health Care Business segment includes the manufacture and sale of health food and cosmetics.